Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

LeMaitre Vascular Q3 EPS $0.33 Beats $0.30 Estimate, Sales $47.41M Miss $47.59M Estimate

Author: Benzinga Newsdesk | November 01, 2023 05:40pm
LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.30 by 10 percent. This is a 32 percent increase over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $47.41 million which missed the analyst consensus estimate of $47.59 million by 0.38 percent. This is a 21.48 percent increase over sales of $39.03 million the same period last year.

Posted In: LMAT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist